Nitrous acid (HNO2) is the major gasphase acid in environmental tobacco smoke (1) and in its vapor phase is found in automobile emissions. Although outdoor ambient concentrations are less than those of sulfuric acid (H2SO4) and nitric acid (HNO3), up to 8 ppb HNO2 has been measured in ambient air in California during an air pollution episode (2) . In homes with combustion sources, elevated HNO2 levels may be associated with direct emissions from the source as well as with reactions of emitted NO2 with water vapor in air. Indoor concentrations of HNO2 are higher than outdoor concentrations, even when indoor concentrations of NO2 do not exceed outdoor levels. Peak levels of HNO2 may exceed 50 ppb and persist for several hours (3, 4) . Nitrous acid may also be a secondary reaction product of NO2 with water on indoor surfaces and, under experimental conditions, has been found to make up as much as 10% of oxides of nitrogen after an interval of reaction (5) . Conventional assays of NO2 measure several oxides of nitrogen together, including HNO2. For this reason, previous studies of respiratory effects of indoor NO2 may have induded exposures to HNO2 without independent measurement of exposure and effect (6) .
Based on in vitro studies, it has been postulated that at environmental concentrations HNO2 is formed within the respiratory system predominantly by hydrogen abstraction (2) , with subsequent conversion of HNO2, at physiologic pH, to H+, and NO2- (2) . It has been proposed that HNO2 formed in this way may contribute to the bronchoconstricting effects of NO2 seen in normal subjects and asthmatics. Studies of the direct effects of HNO2 on the human respiratory system are thus of interest because exposures may occur from primary indoor and outdoor sources or from reaction products of NO2 formed within the human respiratory system. A need for more information on the health effects of HNO2 has recently been identified (8) .
We performed a chamber exposure study to determine whether there is an effect on respiratory symptoms or lung mechanics in a group of patients (mild asthmatics) who have been demonstrated in some but not all studies to be sensitive to other acid species (9L12). We used a concentration of HNO2 higher than that usually measured in homes with unvented combustion sources (4) , but the duration of exposure was shorter than may occur in such homes.
Methods
Subjects. The protocol was approved by the Yale University School of Medicine Human Investigations Committee, and all subjects gave informed consent to participate. The 11 subjects were recruited by advertisements and were selected using the following inclusion criteria: age between 18 and 40 years, nonsmoking, and in good general health other than mild asthma (as defined by a physician's diagnosis with typical symptoms and occasional but not regular use of bronchodilator medications). In addition to these criteria, all subjects had baseline forced expiratory volume in 1 sec (FEVy) and forced vital capacity (FVC) within the normal range for age, sex, and height (13) (14) . Subjects then rested in a seated position within the chamber until the next exercise session. A final spirometry and questionnaire were completed at the end of 180 min, just before leaving the chamber. Symptoms. Subjects completed the same symptom questionnaire five times over each exposure session. They rated each symptom by placing a mark on a 10-cm continuous line representing a score of "absent" through "the most severe ever experienced." Four respiratory symptoms (shortness of breath, wheeze, cough, chest tightness), six sensory irritant questions (skin irritation, eye irritation, eye tearing, throat irritation, nasal stuffiness, nasal dryness), and one negative control question (headache) were induded.
Generation ofHNO2. Nitrous acid was generated by a reaction of sodium nitrite with sulfuric acid using the method of Taira and Kanda (15) . A solution of 0.08 M sulfuric acid and a solution of 0.06 M sodium nitrite were prepared with distilled deionized water. A peristaltic pump added each of the solutions at 2 ml/min onto a circular piece of fritted glass, which was located near the base of the reaction chamber. Ambient air was filtered through a system of Purafil (potassium permanganatecoated aluminum) and activated charcoal and passed into the reaction chamber below the glass frit at 20 L/min. The cleaned air passed through the glass frit and bubbled through the reagent mixture, removing HNO2 from the solution. The mixture was passed through a condensing chamber to remove excess water vapor. This HNO2-containing gas was then fed into the exposure chamber. Excess reagent was removed from the reaction chamber by three tubes located 8 mm above the reagent inlet, and connected to a vacuum flask and a vacuum pump.
Measurement of HNO2. We monitored the nitrous acid concentration in the chamber air by a continuous method using a chemiluminescent NOX analyzer with a system of filters and a valve. Two filter packs were set up in parallel to the NOX analyzer inlet, with a valve switching from one filter pack to the other every 2 min. One filter pack contained a glass-fiber filter coated with sodium carbonate and glycerol, and the other contained an uncoated filter. The coated filter removed the HNO2 from the air passing through it, while allowing the NO and NO2 to pass through. The uncoated filter did not remove any of these gases. The NOX analyzer measured HNO2 as the difference in signal with and without the coated filter.
We also used a noncontinuous method of measuring HNO2 employing the Harvard EPA Annular Denuder System (16) with two denuders in series sampling at 4 L/min. In this system the sample air passed through the space between concentric glass tubes (the annular denuder), which was coated with sodium carbonate and glycerol. Nitrous acid diffused to the coated walls and was trapped, while nonacidic gases passed through uncollected. The denuders were extracted with ultra-pure water after the sampling period. Mean symptom scores reported during exposure were low under both control and exposure conditions, ranging from 0.0 to 1.0 on a 10-point scale ( Table 3) . As reflected in the successful blinding, the subjects were uncertain as to whether exposure sessions were to HNO2 or clean air. However, the aggregate score of all 10 test symptoms was higher on the HNO2 than control days. This difference was small but statistically significant (p = 0.038). The difference between the mean score on exposure and control days for the negative control symptom (headache) was lower than for seven other symptoms and identical to that for wheeze, cough, and nasal stuffiness.
Discussion
Nitrous acid at 650 ppb over a 3-hr ;ent SE of the mary response at this dose, a reduction in ure days was vital capacity, may be due either to inhibilys.
tion of maximal inspiratory effort, a reduction in respiratory system compliance, or closure of airways at higher lung volumes. However, because of the solubility of HNO2 in airway mucosal water and the relatively low concentration tested, it is likely that most of the vapor is absorbed in the respiratory mucosa before reaching terminal bronchioles and alveoli. For this reason, we speculate that the mechanism for this effect is inhibition of maximal inspiration due to effects on sensory afferent nerves. This mechanism has been demonstrated for ozone, a potent respiratory irritant, at 500 ppb (18) . However, because ozone is an aqueous, insoluble gas which is poorly absorbed in the upper airways and HNO2 would be expected to be well absorbed in the upper airways, these data raise the possibility that the effect seen was due to stimulation of upper airway receptors, having the effect of inhibiting maximal inspiration. Asthmatic subjects were chosen for this study as a potentially more sensitive clinical group. Because only asthmatics were studied, we do not know whether nonasthmatic subjects are less susceptible, or more severe asthmatics are more susceptible, to this concentration and duration of exposure.
Nitrous acid is of interest as an environmental exposure due to its presence in emissions from automobiles, natural gas and kerosene-burning appliances, and environmental tobacco smoke. It may also be a reaction product of inhaled NO NO2 + -HC = CH-CH2--* HNO2 + -CH-CH-CHwhich is similar to the mechanism for formation of HNO2 from NO2 postulated on the basis of experimental observations in airways (7, 21) . The rate of tissue absorption of a vapor as it is inhaled in the respiratory system is determined by its concentration, the solubility of the vapor in water, and the rate of airflow. The effective solubility (Henry) coefficient of HNO2 is close to that of sulfur dioxide at physiologic pH (22) , and increases with increasing pH over the range from 2 to 6 (23) . Comparisons of the respiratory effects of acidic gases and aerosols of varying compositions indicate that the hydrogen ion content of the substance is one of the important determinants of the effect on airways. A study of the effect of inhaled acid aerosols in asthmatics has suggested that titratable acidity, as well as the specific chemical composition and pH, are important determinants of the potency of acid in producing effects on lung mechanics (24) .
Asthmatics were selected for the present study because of previously demonstrated susceptibility to airway effects of inhaled acidic aerosol (S9. Increased sensitivity of asthmatic subjects to acidic aerosols has not been seen in all such studies (11, 12) . The duration of the exposure in this study was three times as long as the exposures reported by Avol et al. (11) and Aris et al. (12) , and may account for the significant effect on lung function seen in the present study. Bronchoconstriction was not seen at this dose and duration, even though forced vital capacity was reduced. Further study will be needed to determine whether asthmatics differ in their susceptibility to the effects of vapor-phase HNO2 from nonasthmatics and whether airway constriction is seen at dose-duration combinations higher than those used in this study.
In summary, when exposed for 3 hr with intermittent, moderate exercise to 650 ppb HNO2, mildly asthmatic subjects experienced a small decrease in FVC which was apparent within 25 min of the onset of exposure. They also reported a slightly higher aggregate rate of respiratory and mucous membrane symptoms, although at this dose they were not able to distinguish exposure from control days. These data suggest that the experimental dose of HNO2 used is slightly above but very close to the threshold for respiratory effects of HNO2.
